About Us

Biomedix is a provider of front-line diagnostic solutions for delivering value-based care. We offer a mobile health assessment platform that centralizes data for analyzing population health across multiple chronic conditions, and supports a variety of diagnostic devices.

Biomedix is the maker of PADnet®, the market leader in front-line diagnostics for peripheral vascular disease. PADnet is the only diagnostic device that can support the identification of peripheral artery disease (PAD) and chronic venous insufficiency (CVI) through a unique collaborative care model, which enables the cost-effective delivery of care that optimizes patient outcomes.

The Founders:

The founders of Biomedix are comprised of leaders from healthcare, including healthcare pioneer Dr. Tom Fogarty, finance, industry and service businesses. Our Founders believe that PADnet and the related network and services are well aligned with expanding efforts to reduce healthcare system costs while improving quality outcomes through earlier detection and community-based collaboration.

Contact us today to learn more about partnering with Biomedix to improve the management of PAD and CVI through physician collaboration in your community.

Upcoming events:
  • Wed
    20
    Jun
    2018
    Sat
    23
    Jun
    2018

    AAPPM Summer Conference

    Columbus, OH
  • Thu
    21
    Jun
    2018
    Sat
    23
    Jun
    2018

    Western Foot and Ankle Conference

    Anaheim, CA
  • Thu
    12
    Jul
    2018
    Sun
    15
    Jul
    2018

    APMA National

    Washington DC
Follow Us
Contact Us
  • Email
  • Phone
    888-889-8997
  • Address
    2025 Centre Pointe Blvd, Suite 200
    St. Paul, MN 55120
Sign up


By submitting this form, you are consenting to receive marketing emails from: Biomedix, 2025 Centre Pointe Blvd., St. Paul, MN, 55120, http://www.biomedix.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact